Literature DB >> 24664445

Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.

Irin Perveen1, Mufti Munsurar Rahman, Madhusudan Saha, Mohammad Masudur Rahman, Mohammad Quamrul Hasan.   

Abstract

BACKGROUND: This community-based survey aimed to find out the prevalence of irritable bowel syndrome (IBS), functional dyspepsia (FD), overlapping symptoms, and associated factors for overlap.
METHOD: By cluster sampling method, 3,000 (1,523 male) randomly selected adult subjects in the Sylhet district of Bangladesh were interviewed by a questionnaire based on ROME III criteria. Multivariate logistic regression analyses were done to find out the factors for overlap with significance level set at ≤0.05.
RESULTS: The mean age of the study population was 33.9 ± 16.4 years. Prevalence of IBS and FD and IBS-FD were 12.9 % (n = 387), 8.3 % (n = 249), and 3.5 % (n = 105), respectively. Approximately 27.1 % of IBS patients and 42.1 % of FD patients had overlapping IBS-FD. The odds ratio for IBS-FD overlap was 6.3 (95 % CI, 4.8-8.4). Mean age (p = 0.011) and epigastric pain (p = 0.002) were more in overlap patients than FD alone, whereas epigastric pain syndrome subtype (p < 0.009) was more prevalent in lone FD subjects. In the multivariate logistic analysis, early satiety (OR, 3.0; 95 % CI, 1.2-7.5; p = 0.018) and epigastric pain (OR, 14.5; 95 % CI, 5.0-42.1; p = 0.000) in FD patients appeared as independent risk factors for overlap. Bloating (p = 0.026), <3 stools per week (p = 0.050), abdominal pain reduced by defecation (p = 0.002), abdominal pain severity score (p = 0.004), and overall symptom frequency score (p = 0.000) were more in overlap patients than IBS-alone patients. In IBS patients, bloating (OR, 3.6; CI, 2.0-6.5; p = 0.000) was found as potential symptom associated with IBS-FD overlap.
CONCLUSION: FD was a less prevalent disorder than IBS in our community, and significant overlap existed between the two disorders. Early satiety, epigastric pain, and bloating were important factors associated with overlap.

Entities:  

Mesh:

Year:  2014        PMID: 24664445     DOI: 10.1007/s12664-014-0447-1

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  36 in total

1.  Epidemiology of FGID symptoms in Japanese general population with reference to life style.

Authors:  Michio Hongo
Journal:  J Gastroenterol Hepatol       Date:  2011-04       Impact factor: 4.029

2.  Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.

Authors:  Makiko Kaji; Yasuhiro Fujiwara; Masatsugu Shiba; Yukie Kohata; Hirokazu Yamagami; Tetsuya Tanigawa; Kenji Watanabe; Toshio Watanabe; Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 4.029

3.  Predominant symptoms identify different subgroups in functional dyspepsia.

Authors:  V Stanghellini; C Tosetti; A Paternicò; R De Giorgio; G Barbara; B Salvioli; R Corinaldesi
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

4.  Depressive mood and quality of life in functional gastrointestinal disorders: differences between functional dyspepsia, irritable bowel syndrome and overlap syndrome.

Authors:  Heon-Jeong Lee; Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Choon Jo Jin; Seung-Gul Kang; Hiejin Yoon; Hoon Jai Chun
Journal:  Gen Hosp Psychiatry       Date:  2010-06-25       Impact factor: 3.238

5.  Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population.

Authors:  Ching-Liang Lu; Hui-Chu Lang; Full-Young Chang; Chih-Yen Chen; Jiing-Chyuan Luo; Sun-Sang Wang; Shou-Dong Lee
Journal:  Scand J Gastroenterol       Date:  2005-04       Impact factor: 2.423

6.  Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features.

Authors:  W F Stewart; J N Liberman; R S Sandler; M S Woods; A Stemhagen; E Chee; R B Lipton; C E Farup
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

Review 7.  Irritable bowel syndrome in developing countries--a disorder of civilization or colonization?

Authors:  K-A Gwee
Journal:  Neurogastroenterol Motil       Date:  2005-06       Impact factor: 3.598

8.  A database on dyspepsia.

Authors:  G P Crean; R J Holden; R P Knill-Jones; A D Beattie; W B James; F M Marjoribanks; D J Spiegelhalter
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

9.  The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.

Authors:  Anjiang Wang; XianHua Liao; LiShou Xiong; Sui Peng; YingLian Xiao; SiChun Liu; PinJin Hu; MinHu Chen
Journal:  BMC Gastroenterol       Date:  2008-09-23       Impact factor: 3.067

10.  Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome.

Authors:  Shadi S Yarandi; Jennifer Christie
Journal:  Gastroenterol Res Pract       Date:  2013-05-16       Impact factor: 2.260

View more
  15 in total

1.  Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.

Authors:  Masayoshi Ono; Mototsugu Kato; Shuichi Miyamoto; Momoko Tsuda; Takeshi Mizushima; Shouko Ono; Manabu Nakagawa; Katsuhiro Mabe; Soichi Nakagawa; Shuichi Muto; Yuichi Shimizu; Mineo Kudo; Shinichi Katsuki; Takashi Meguro; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-01-05       Impact factor: 7.527

Review 2.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.

Authors:  Gerald Holtmann; Dietmar Schrenk; Ahmed Madisch; Hans D Allescher; Gudrun Ulrich-Merzenich; Fermin Mearin; Dominique Larrey; Peter Malfertheiner
Journal:  Dig Dis       Date:  2019-11-26       Impact factor: 2.404

3.  Prevalence of Irritable Bowel Syndrome (IBS), Migraine and Co-Existing IBS-Migraine in Medical Students.

Authors:  Irin Perveen; Rukhsana Parvin; Madhusudan Saha; Md Shafiqul Bari; Md Nazmul Huda; Mridul Kanti Ghosh
Journal:  J Clin Diagn Res       Date:  2016-11-01

4.  Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.

Authors:  Vladimir T Ivashkin; Anna V Kudryavtseva; George S Krasnov; Yuri M Poluektov; Margarita A Morozova; Oleg S Shifrin; Allan G Beniashvili; Zarina A Mamieva; Alexandra L Kovaleva; Anatoly I Ulyanin; Elizaveta A Trush; Alexander G Erlykin; Elena A Poluektova
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

Review 5.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

6.  Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

7.  Overlap in patients with dyspepsia/functional dyspepsia.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Neurogastroenterol Motil       Date:  2014-09-26       Impact factor: 4.924

8.  Translation and Validation of Enhanced Asian Rome III Questionnaires in Bengali Language for Diagnosis of Functional Gastrointestinal Disorders.

Authors:  M Masudur Rahman; Uday C Ghoshal; A H M Rowshon; Faruque Ahmed; Md Golam Kibria; Mahmud Hasan; Kok-Ann Gwee; William E Whitehead
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

Review 9.  Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.

Authors:  M Masudur Rahman; Sanjiv Mahadeva; Uday C Ghoshal
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

10.  Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation.

Authors:  Mousalreza Hosseini; Roshanak Salari; Mina Akbari Rad; Maryam Salehi; Batul Birjandi; Masoumeh Salari
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.